ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 155 filers reported holding ASCENDIS PHARMA A/S in Q3 2020. The put-call ratio across all filers is 0.38 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,293,712 | +4.9% | 24,495 | 0.0% | 0.99% | +4.7% |
Q2 2023 | $2,186,179 | -21.6% | 24,495 | -5.9% | 0.95% | -19.7% |
Q1 2023 | $2,789,543 | -12.2% | 26,017 | -0.0% | 1.18% | -23.1% |
Q4 2022 | $3,178,189 | +18.3% | 26,023 | 0.0% | 1.54% | +2.5% |
Q3 2022 | $2,687,000 | +23.9% | 26,023 | +11.6% | 1.50% | +38.1% |
Q2 2022 | $2,168,000 | -37.8% | 23,322 | -21.5% | 1.08% | -21.1% |
Q1 2022 | $3,488,000 | -29.7% | 29,722 | -19.5% | 1.38% | -10.1% |
Q4 2021 | $4,964,000 | -15.6% | 36,899 | 0.0% | 1.53% | -17.5% |
Q3 2021 | $5,881,000 | +25.8% | 36,899 | +3.8% | 1.85% | +38.6% |
Q2 2021 | $4,676,000 | +2.3% | 35,544 | +0.2% | 1.34% | -3.0% |
Q1 2021 | $4,573,000 | -29.3% | 35,484 | -8.5% | 1.38% | -38.9% |
Q4 2020 | $6,468,000 | +8.1% | 38,783 | 0.0% | 2.26% | -7.7% |
Q3 2020 | $5,985,000 | +4.3% | 38,783 | +0.0% | 2.44% | +1.8% |
Q2 2020 | $5,736,000 | +150.0% | 38,782 | +90.4% | 2.40% | +103.8% |
Q1 2020 | $2,294,000 | +96.1% | 20,369 | +142.3% | 1.18% | +159.5% |
Q4 2019 | $1,170,000 | -5.9% | 8,407 | -34.9% | 0.45% | -14.3% |
Q3 2019 | $1,243,000 | +28.4% | 12,907 | +53.5% | 0.53% | +27.7% |
Q2 2019 | $968,000 | +134.4% | 8,407 | +139.7% | 0.42% | +121.9% |
Q1 2019 | $413,000 | – | 3,507 | – | 0.19% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,865,338 | $978,221,000 | 13.68% |
Vivo Capital, LLC | 1,797,745 | $299,828,000 | 13.38% |
Sofinnova Investments, Inc. | 1,109,874 | $185,105,000 | 11.02% |
Avoro Capital Advisors LLC | 1,800,000 | $300,204,000 | 5.17% |
Eventide Asset Management | 1,704,148 | $284,218,000 | 4.36% |
Stenahm Asset Managment Ltd | 29,000 | $4,837,000 | 4.07% |
Ghost Tree Capital, LLC | 105,000 | $17,512,000 | 3.90% |
Eversept Partners, LP | 187,043 | $31,195,032 | 3.66% |
Spyglass Capital Management LLC | 701,594 | $117,012,000 | 3.59% |
Q Global Advisors, LLC | 23,183 | $3,866,000 | 2.72% |